Jinsanjiang announced its 2026 interim report on August 25. First-half operating revenue reached 276 million yuan, up 37.82% year on year. Net profit attributable to shareholders of the listed company was 44.43 million yuan, up 44.08% year on year. Net profit attributable to shareholders after deducting non-recurring items was 43.60 million yuan, up 43.87% year on year. The company also released a draft equity incentive plan, proposing to grant 4.06 million stock options to its core team, accounting for about 1.76% of total share capital. Of these, 3.25 million options will be granted initially and 810,000 reserved. The initial grant covers 27 incentive recipients, with an exercise price set at 11.26 yuan per share. The exercise assessment condition uses 2025 operating revenue as the base, with annual revenue growth targets for 2026 through 2030 all set at 15%. As a national-level specialized and innovative "little giant", Jinsanjiang is deepening its presence in oral care while expanding into high-value-added areas such as food and pharmaceuticals, high-end industrial applications, and high-performance tires. Some new products have already begun shipping and passed customer validation.
Jinsanjiang (Zhaoqing) Silicon Material Company LimitedFirst-half net profit up 44% and revenue up 37.82%, with an equity incentive plan tied to 15% annual revenue growth.
